by European Public Health Alliance | Jul 8, 2021 | Opinion
Undeniably, pharmaceutical companies’ power and influence have grown in the context of the current pandemic. The politicisation of pharmaceuticals is unprecedented. Pharma CEOs pick up the phone and talk directly to EU heads of state and governments. Companies are...
by European Public Health Alliance | Jul 8, 2021 | Opinion
Guest article: Ella Weggen & Marianne Meijer, Global Health Advovates, Wemos TRIPS waiver, C-TAP, the use of compulsory licensing, donations through COVAX – various strategies have been proposed to increase global access to COVID-19 vaccines. One way or another,...
by European Public Health Alliance | Jul 8, 2021 | Opinion
Guest article by Jaume Vidal, Senior Policy Advisor, Health Action International The COVID-19 pandemic, and the efforts of governments and international organisations to counter it, has laid bare the pre-existing contradictions and shortcomings in the current...
by European Public Health Alliance | Jun 29, 2021 | Position & Policy Papers
EPHA publishes new recommendations to ensure vaccine equity across the EU In the light of a more comprehensive and global vision of health, the current pandemic has proven to intensify many pre-existing social and health disparities worldwide as well as within the...
